Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)

NCT07290257 is registered in ClinicalTrials.gov with Mirum Pharmaceuticals, Inc. as lead sponsor.

NCT NCT07290257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07290257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)
Lead sponsor
Mirum Pharmaceuticals, Inc.
Phase
Phase 4
Overall status
Recruiting
Start date
September 25, 2025
Completion date
December 22, 2030
Enrollment
230 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

alagille syndrome, progressive familial intrahepatic cholestasis